Osteogenesis imperfecta is a group of rare hereditary diseases of connective tissue, which are based on a defective collagen formation. The main focus of the osteogenesis imperfecta drug therapy is a cyclical use of bisphosphonates (pamidronic acid). The
A. A. Bakirov +8 more
doaj +1 more source
Mutational spectrum of type I collagen genes in Korean patients with osteogenesis imperfecta [PDF]
Kwang-Soo Lee +9 more
openalex +1 more source
Genotypic Characterization of a Chinese Family with Osteogenesis Imperfecta and Generation of Disease-Specific Induced Pluripotent Stem Cells [PDF]
Dandan Li +11 more
openalex +1 more source
Perinatal lethal type II osteogenesis imperfecta: a case report [PDF]
Imene Dahmane Ayadi +4 more
openalex +1 more source
Osteogenesis imperfecta - Clinical and molecular diversity
Osteogenesis imperfecta is a heritable disorder of bone formation resulting in low bone mass and a propensity to fracture. It exhibits a broad range of clinical severity, ranging from multiple fracturing in utero and perinatal death to normal adult ...
Roughley P. J., Rauch F., Glorieux F. H.
doaj
Quantitative increase in T regulatory cells enhances bone remodeling in osteogenesis imperfecta
In‐Hong Kang +10 more
openalex +1 more source
Osteogenesis imperfecta - multi-systemic and life-long disease that affects whole family [Osteogenesis imperfecta - više-sustavna, doživotna bolest i njen utjecaj na obitelj] [PDF]
Osteogenesis imperfecta or brittle bone disease, a heritable disorder of connective tissue, is the most common of the inherited disorders primarily affecting bone. There are approximately 400 individuals with OI in Croatia alone.
Antičević, Darko +4 more
core
Prognostic factors for mobility in children with osteogenesis imperfecta
Kenta Sawamura +4 more
openalex +1 more source
Physiotherapy and patients with osteogenesis imperfecta: an experience report [PDF]
Carmem Lia Martins Moreira +4 more
openalex +1 more source

